摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tert-butyl 4-[(2R)-2-hydroxy-3-(2-phenylbenzoxazol-5-yloxy)propyl]-piperazinecarboxylate | 1055966-79-4

中文名称
——
中文别名
——
英文名称
tert-butyl 4-[(2R)-2-hydroxy-3-(2-phenylbenzoxazol-5-yloxy)propyl]-piperazinecarboxylate
英文别名
tert-butyl 4-[(2R)-2-hydroxy-3-[(2-phenyl-1,3-benzoxazol-5-yl)oxy]propyl]piperazine-1-carboxylate
tert-butyl 4-[(2R)-2-hydroxy-3-(2-phenylbenzoxazol-5-yloxy)propyl]-piperazinecarboxylate化学式
CAS
1055966-79-4
化学式
C25H31N3O5
mdl
——
分子量
453.538
InChiKey
JRKIQTUHRLQDGZ-LJQANCHMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    33
  • 可旋转键数:
    8
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    88.3
  • 氢给体数:
    1
  • 氢受体数:
    7

文献信息

  • [EN] SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CARDIOVASCULAR DISEASES<br/>[FR] COMPOSES HETEROCYCLIQUES SUBSTITUES UTILES POUR LE TRAITEMENT DE MALADIES CARDIO-VASCULAIRES
    申请人:CV THERAPEUTICS INC
    公开号:WO2004069818A1
    公开(公告)日:2004-08-19
    wherein: a.o. T is oxygen, sulfur, or NR11 , in which R11 is hydrogen or lower alkyl; V is -N<, -CH<, or -NH-CH<; X1 is hydrogen, optionally substituted lower alkyl, optionally substituted cycloalkyl, optionally substituted aryl, or optionally substituted heteroaryl; X2 is optionally substituted aryl or optionally substituted heteroaryl; Y is optionally substituted dihydroheteroarcyl; and Z1 and Z2 are independently optionally substituted alkylene of 1-4 carbon atoms, useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal’s (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, and myocardial infarction. The compounds are also useful in the treatment of diabetes.
    其中:a.o. T是氧、或NR11,其中R11是氢或较低的烷基;V是-N<,-CH<或-NH-CH<;X1是氢,可选择取代的较低烷基,可选择取代的环烷基,可选择取代的芳基或可选择取代的杂芳基;X2是可选择取代的芳基或可选择取代的杂芳基;Y是可选择取代的二氢杂芳基;Z1和Z2分别是1-4个碳原子的可选择取代的烷基,用于治疗各种疾病状态,特别是心血管疾病,如心房和心室心律失常、间歇性跛行、普林兹梅塔(变异)心绞痛、稳定和不稳定心绞痛、运动诱发性心绞痛、充血性心脏病和心肌梗死。这些化合物还可用于治疗糖尿病。
  • Substituted heterocyclic compounds
    申请人:——
    公开号:US20040186109A1
    公开(公告)日:2004-09-23
    Disclosed are novel heterocyclic derivatives, useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, and myocardial infarction. The compounds are also useful in the treatment of diabetes.
    本发明涉及新型杂环衍生物,可用于治疗各种疾病状态,特别是心血管疾病,如心房和心室心律失常、间歇性跛行、普林兹梅特尔(变异性)心绞痛、稳定和不稳定性心绞痛、运动诱发性心绞痛、充血性心力衰竭和心肌梗塞。该化合物还可用于治疗糖尿病。
  • SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CARDIOVASCULAR DISEASES
    申请人:CV THERAPEUTICS, INC.
    公开号:EP1583751A1
    公开(公告)日:2005-10-12
  • US7026321B2
    申请人:——
    公开号:US7026321B2
    公开(公告)日:2006-04-11
查看更多